Welcome to the e-CCO Library Archive!
J. Landy1, H. Omar Al-Hassi2, E. Mann2, S. Peake1, P.J. Ciclitira3, R.J. Nicholls4, S.K. Clark5, S. Knight2, A.L. Hart1, 1St Mark's Hospital, IBD Unit, London, United Kingdom, 2Antigen Presentation Research Group, Imperial College, London, United Kingdom, 3St Thomas' Hospital, Gastroenterology, London, United Kingdom, 4Imperial College, Department of Biosurgery and Surgical Technology, London, United Kingdom, 5St Mark's Hospital, Colorectal Surgery, London, United Kingdom
H2S confers colonoprotection against TNBS-induced colitis by HO-1 upregulation in rats
K. Kupai*, M. Veszelka, S. Török, Z. Szalai, A. Pósa, C. Varga
University of Szeged, Faculty of Science and Informatics, Department of Physiology, Anatomy and Neuroscience, Szeged, Hungary
Intraperitoneally injected mesenchymal stromal cells home significantly more often to the intestines in colitis mice compared to healthy controls
I. Molendijk1, J.M. Perez Galarza2, E.S. de Jonge-Muller1, A.E. van der Meulen-de Jong1, W.E. Fibbe2, D.W. Hommes3, M. van Pel2, H.W. Verspaget1, 1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, 2Leiden University Medical Center, Immunohematology and Blood Transfusion, Leiden, Netherlands, 3University of California Los Angeles, Digestive Diseases, Los Angeles, United States
The influence of anti-TNF therapy on chosen angiogenesis-related processes in patients with Crohn's disease
P. Eder*1, L. Lykowska-Szuber1, K. Korybalska2, A. Wozniak3, I. Krela-Kazmierczak1, K. Stawczyk-Eder1, K. Klimczak1, A. Szymczak1, K. Linke1, J. Witowski2
1Poznan University of Medical Sciences, Department of Gastroenterology, Human Nutrition and Internal Diseases, Poznan, Poland, 2Poznan University of Medical Sciences, Department of Pathophysiology, Poznan, Poland, 3Poznan University of Medical Sciences, Department of Clinical Pathomorphology , Poznan, Poland
Interleukin 22 and interleukin 23R gene expression in Crohn's disease: preliminary results
N. Ben Mustapha, A. Labidi, Y. Kardous, M. Serghini, M. Fekih, J. Boubaker, A. Filali, La Rabta Hospital, Gastroenterology A, Tunis, Tunisia
S. D'Alessio1, C. Tacconi1, C. Correale1, A. Gandelli1, S. Danese1, 1Istituto Clinico Humanitas, Rozzano, Italy
The N- acyl-homoserine lactone 3-oxo-C12, an inter-bacterial signaling molecule (involved in quorum sensing), exerts effects on the host: thus implicating quorum sensing in inflammatory bowel disease.
C. Landman*1, M. Clément1, H. Nsiri1, E. Quévrain1, T. Bazin1, L. Brot1, J.-P. Grill1, M.-A. Maubert1, L. Humbert1, H. Sokol1, 2, G. Trugnan1, D. Rainteau1, P. Seksik1, 2
1UPMC, ERL INSERM 1157 / UMR7203, PARIS, France, 2APHP Saint-Antoine, Service de Gastroentérologie et nutrition, Paris, France
Interleukin 10 (IL10) expression and distribution pattern in healthy and inflamed bowel. Relationship with steroid response in Crohn's disease (CD)
A. Carrasco, F. Fernández-Bañares, C. Loras, E. Pedrosa, M. Aceituno, M. Rosinach, R. Temiño, M. Forné, E. Sainz, X. Andújar, M. Esteve, Hospital Universitari Mútua Terrassa. UB, Gastroenterology, Terrassa, Spain
C. Breynaert1, C. Perrier1, J. Cremer1, L. Coorevits2, M. Ferrante1, S. Vermeire1, P. Rutgeerts1, C. Uyttenhove3, J. Van Snick3, J. Ceuppens2, G. Van Assche1, 1KU Leuven, TARGID, Leuven, Belgium, 2KU Leuven, Clinical immunology, Leuven, Belgium, 3Brussels Branch, Ludwig Institute for Cancer Research, Brussels, Belgium
Allograft inflammatory factor-1 (AIF-1) stimulates Th1 differentiation of human T-cells and protects them from apoptosis
D. Cano-Martínez*1, J. Monserrat2, B. Hernández-Breijo1, P. Sanmartín-Salinas1, I.D. Román1, M.D. Fernández-Moreno1, S. Marsal3, J.P. Gisbert4, L. Guijarro1
1Universidad de Alcalá and CIBERehd, Systems Biology, Alcalá de Henares, Spain, 2Universidad de Alcalá, Medicine and Medical Specialties, Alcalá de Henares, Spain, 3Hospital Universitari Vall d'Hebron, Gastroenterology Unit, Barcelona, Spain, 4Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Gastroenterology Unit, Madrid, Spain
Interleukin-17A homodimer reduces pro-inflammatory cytokine production by inflammatory bowel disease mucosa cultured ex vivo
P. Biancheri1,2, A. Di Sabatino2, R. Curciarello1, P. Giuffrida2, F. Ammoscato1, G.R. Corazza2, J.O. Lindsay3, T.T. MacDonald1, 1Barts and The London School of Medicine and Dentistry, Centre for Immunology and Infectious Disease, London, United Kingdom, 2Fondazione IRCCS Policlinico S. Matteo, University of Pavia, First Department of Medicine, Pavia, Italy, 3Barts and The London School of Medicine and Dentistry, Centre for Digestive Diseases, London, United Kingdom
R. Ramonaite1, L. Jonaitis1, G. Kiudelis1, A. Tamelis2, J. Skieceviciene1, V. Borutaite3, L. Kupcinskas1, 1Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania, 2Lithuanian University of Health Sciences, Department of Surgery, Kaunas, Lithuania, 3Lithuanian University of Health Sciences, Institute of Neurosciences, Kaunas, Lithuania